Andrew is Managing Director and Head of the Healthcare Investment Banking Group for BMO Capital Markets. Andrew has spent his entire 25-plus year career covering the Healthcare sector. He has served as advisor on more than $135 billion of M&A transactions, as well as debt and equity financings, for large and small companies, including CVS Health, Agiliti Health, Kindred Healthcare, GreatCall, Diplomat Pharmacy, Quest Diagnostics, Select Medical, and HCA Healthcare.
Andrew joined BMO from JP Morgan where he was a Managing Director in Healthcare Investment Banking. Prior to that, he served as Co-Head of Healthcare Services at Deutsche Bank and served in similar capacity at Morgan Stanley, where he helped build its healthcare services investment banking franchise.
Prior to his career as an investment banker, Andrew was a senior equity research analyst responsible for coverage of the healthcare provider and services sector. Andrew also serves as a Visiting Scholar at the Yale School of Management, on the Leadership Council for the Dean of the Yale School of Public Health, and on the Advisory Board for the Yale Healthcare.
Andrew attended Yale University for his M.P.H. and received his B.G.S. from Kent State University.
BMO Capital Markets is a trade name used by BMO Financial Group for the wholesale banking businesses of Bank of Montreal, BMO Harris Bank N.A. (member FDIC), Bank of Montreal Europe p.l.c, and Bank of Montreal (China) Co. Ltd and the institutional broker dealer businesses of BMO Capital Markets Corp. (Member FINRA and SIPC) in the U.S., BMO Nesbitt Burns Inc. (Member Investment Industry Regulatory Organization of Canada and Member Canadian Investor Protection Fund) in Canada and Asia, Bank of Montreal Europe p.l.c. (authorised and regulated by the Central Bank of Ireland) in Europe and BMO Capital Markets Limited (authorised and regulated by the Financial Conduct Authority) in the UK and Australia.